Änderungen

*[[Curcumin]] (auch ''Kurkumin'')

*[[Curcumin]] (auch ''Kurkumin'')

*[[TBL-12]]

*[[TBL-12]]

*Dendritic Cells - Therapie, offenbar in Zusammenhang mit der Praxis Nesselhut in Duderstadt<ref>https://www.goettinger-tageblatt.de/Die-Region/Duderstadt/Besuch-im-Reinraumlabor-Thomas-Nesselhuts-Krebstherapie-in-Duderstadt</ref>. Mehrere Hallwang-Patienten berichten übereinstimmend von Dornstetten aus nach Duderstadt zu Thomas Nesselhut gefahren worden zu sein.

*Dendritic Cells - Therapie, offenbar in Zusammenhang mit der Praxis Nesselhut in Duderstadt<ref>https://www.welt.de/gesundheit/plus158780242/Wann-wird-Alternativmedizin-zur-Gefahr.html</ref><ref>https://www.goettinger-tageblatt.de/Die-Region/Duderstadt/Besuch-im-Reinraumlabor-Thomas-Nesselhuts-Krebstherapie-in-Duderstadt</ref>. Mehrere Hallwang-Patienten berichten übereinstimmend von Dornstetten aus nach Duderstadt zu Thomas Nesselhut gefahren worden zu sein.

*Immuntherapie: ''"Now, sophisticated high-throughput technologies enable the identification of  these mutated genes in cancers, leading to potent targeted immunotherapy - by so called tumor-associated–antigen-multiplex-THX-Vaccination-Strategy. Particularly THX-Vaccination-Strategies against the tumor antigens or mutated antigens have shown amazing results, showing a stronger anti-tumor immune response than several dendritic cell vaccinations. In comparison to the often used single-THX-Vaccination-Strategy - "one THX against one tumor antigen" - that is limited by the so called MHC-class-match and by the fact that one THX might not be efficient to induce an immune response or can be bypassed quickly, we have established a Multiplex-THX-Vaccination-Strategy that includes all therapeutic relevant immunogenic THX’s against one tumor antigen - "Multiplex Immunogenic THX’s (50-200 THX’s) against one tumor antigen. Furthermore, we are using the Multiplex THX’s in combination with the most upfront immuno-adjuvants. Our adjuvants have been optimized in order to improve efficacy and stability of the Multiplex THX Vaccine formulations and to reduce side effects..."'' (9500 + 3800 Euro)

*Immuntherapie: ''"Now, sophisticated high-throughput technologies enable the identification of  these mutated genes in cancers, leading to potent targeted immunotherapy - by so called tumor-associated–antigen-multiplex-THX-Vaccination-Strategy. Particularly THX-Vaccination-Strategies against the tumor antigens or mutated antigens have shown amazing results, showing a stronger anti-tumor immune response than several dendritic cell vaccinations. In comparison to the often used single-THX-Vaccination-Strategy - "one THX against one tumor antigen" - that is limited by the so called MHC-class-match and by the fact that one THX might not be efficient to induce an immune response or can be bypassed quickly, we have established a Multiplex-THX-Vaccination-Strategy that includes all therapeutic relevant immunogenic THX’s against one tumor antigen - "Multiplex Immunogenic THX’s (50-200 THX’s) against one tumor antigen. Furthermore, we are using the Multiplex THX’s in combination with the most upfront immuno-adjuvants. Our adjuvants have been optimized in order to improve efficacy and stability of the Multiplex THX Vaccine formulations and to reduce side effects..."'' (9500 + 3800 Euro)

*Anti-Hormontherapie

*Anti-Hormontherapie